Contract Development Services

In Safe Hands

August 02, 2019

Pharmaceutical Technology Europe

Complex and potent molecules demand greater technical and regulatory expertise to ensure safe handling.

Catalent Extends Spray Drying Capabilities in Europe

July 16, 2019

An agreement with Sanofi gives Catalent access to commercial spray drying facility in Haverhill, UK.

Piramal Pharma Solutions Invests $10 million to Expand HPAPI Capability

June 20, 2019

The company has expanded its high-potency API capability at its Riverview, MI, facility to serve the growing antibody drug conjugates market.

Lonza Expands HPAPI Capacity

June 17, 2019

Two additional production lines expand Lonza’s HPAPI capacity at Visp, Switzerland facility.

Tergus Pharma Plans Commercial Manufacturing Facility

June 07, 2019

Tergus Pharma announced a partnership with Great Point Partners and construction of a new commercial manufacturing facility in North Carolina.

Particle Sciences Gains DEA Schedule I Registration

May 28, 2019

Expanded controlled substance capabilities enables Particle Sciences to develop and manufacture Schedule I–V drugs.

WuXi Biologics to Build New Manufacturing Center in China

May 17, 2019

The company announced plans to construct a 1.3 million-ft2 integrated manufacturing center in Chengdu, China.

Recipharm Launches Development and Manufacturing Service for Inhalation Products

May 09, 2019

Recipharm Inhalation Solutions is an integrated service for inhalation products.

Samsung BioLogics, GI Innovation Partner on Immunochemotherapy

May 08, 2019

Samsung BioLogics will provide contract development organization services to drug developer GI Innovation.

Integrated First-in-Human Service Package for Poorly Soluble Small Molecules

April 30, 2019

Lonza’s SimpliFiH Services addresses bioavailability challenges with drug substance, solid-state characterization, and drug product for first-in-human studies.